Type 2 diabetes in children and adolescents – the next epidemic?

References

• Scott CR, Smith JM, Cradock, et al. Characteristics of youth-onset and noninsulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis. Pediatrics 1997;100:84–91
   PubMed Web of Science ®Google Scholar
• Dabelea D, Hanson RL, Bennett PH, et al. Increasing prevalence of type II diabetes in American Indian children. West J Med 1998;168:11–16
   PubMedGoogle Scholar
• Fago-Campagna A, Burrows NR, Williamson DF. The public health epidemiology of type 2 diabetes in children and adolescents: a case study of American Indian adolescents in the southwestern United States. Clin Chim Acta 1999;286: 81–95
   Google Scholar
• Kitagawa T, Owada M, Urakami T, et al. Increased incidence of non-insulin dependent diabetes mellitus among Japanese schoolchildren correlates with an increased intake of animal protein and fat. Clin Pediatr 1998;37:111–16
   PubMed Web of Science ®Google Scholar
• Dean H. NIDDM-Y in first nation children in Canada. Clin Pediatr 1998;37:89–96
   PubMed Web of Science ®Google Scholar
• Rosenbloom AL, Joe JR, Young RS, et al. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999;2:345–54
   Google Scholar
• Bloomgarden ZT. Type 2 diabetes in the young. Diabetes Care 2004;27:998–1010
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention: overweight children and adolescents 6–19 years of age, according to sex, age, race, and Hispanic origin: United States, selected years 1963–65 through 1999–2000. Available from http://www.cdc.gov/nchs/data/hus/tables/2002/02hus071.pdf [Accessed 27 April 2003]
   Google Scholar
• Kahn SE. The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001;86:4047–58
   PubMed Web of Science ®Google Scholar
• Buse JB. Progressive use of medical therapies in type 2 diabetes. Diabetes Spectrum 2000;13:211–20
   Google Scholar
• DeFronzo R. Pharmacological therapy for type 2 diabetes. Ann Inter Med 1999;17:281–303
   Google Scholar
• Dinneen S, Gerich J, Rizza R. Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med 1992;327:707–13
   Google Scholar
• Pearson ER, Liddell WG, Shepherd M, et al. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1 alpha gene mutations: evidence for pharmacogenetics in diabetes. Diabet Med 2000;17:543–5
   PubMed Web of Science ®Google Scholar
• Horikawa Y, Oda N, Cox NJ, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000;26:163–175
   PubMed Web of Science ®Google Scholar
• Phipps K, Barker DJP, Hales CN, et al. Fetal growth and impaired glucose tolerance in men and women. Diabetologia 1993;36:225–8
   PubMed Web of Science ®Google Scholar
• Phillips DIW, Barker DJP, Hales CN, et al. Thinness at birth and insulin resistance in adult life. Diabetologia 1994;37:150–4
   PubMed Web of Science ®Google Scholar
• McCance DR, Pettitt DJ, Hanson RL, et al. Birth weight and non- insulin dependent diabetes: ‘thrifty genotype’, ‘thrifty phenotype’, or ‘surviving baby genotype’. BMJ 1994;308:942–45
   PubMed Web of Science ®Google Scholar
• Hales CN, Barker DJP. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992;35:595–601
   PubMed Web of Science ®Google Scholar
• Li C, Johnson MS, Goran MI. The effects of low birth weight in Caucasians and African American children. Diabetes Care 2001;24:2035–42
   Google Scholar
• Wilkin TJ, Metcalf BS, Murphy MJ, et al. The relative contributions of birth weight, weight change, and current weight to insulin resistance in contemporary 5-year-olds. Diabetes 2002;51:3468–72
   PubMed Web of Science ®Google Scholar
• Invitti C, Guzzaloni G, Gilardini L, et al. Prevalence and concomitants of glucose intolerance in European obese children and adolescents. Diabetes Care 2003;26:118–24
   PubMed Web of Science ®Google Scholar
• Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802–10
   PubMed Web of Science ®Google Scholar
• Arslanian SA, Saad R, Lewy V, et al. Hyperinsulinemia in African American children: decreased insulin clearance and increased insulin secretion and its relationship to insulin sensitivity. Diabetes 2002;51:3014–19
   PubMed Web of Science ®Google Scholar
• Arslanian S. Metabolic differences between Caucasian and African American children and the relationship to type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2002;15:509–17
   PubMed Web of Science ®Google Scholar
• Arslanian S, Danadian K. Insulin secretion, insulin sensitivity and diabetes in black children. J Clin Endocrinol Metab 1998;9:194–9
   Web of Science ®Google Scholar
• Amiel SA, Sherwin RS, Simonson DC, et al. Impaired insulin action in puberty: a contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 1986;315:215–19
   PubMed Web of Science ®Google Scholar
• Bloch CA, Clemons P, Sperling MA. Puberty decreases insulin sensitivity. J Pediatr 1987;110:481–7
   Google Scholar
• American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care 2000;23:381–9
   PubMed Web of Science ®Google Scholar
• Rosenbloom AL, Joe JR, Young RS, et al. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999;22:345–54
   PubMed Web of Science ®Google Scholar
• Bricker LA, Draznin MB, Hare JD, et al. Diabetes in adolescent patients: diagnostic dilemmas. Indian J Pediat 2001;68:223–7
   PubMedGoogle Scholar
• Rocchini AP, Katch V, Schork A, et al. Insulin and blood pressure during weight loss in obese adolescents. Hypertension 1987;10:267–73
   PubMed Web of Science ®Google Scholar
• Freemark M, Bursey D. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics 2001;107:E55
   PubMed Web of Science ®Google Scholar
• Kay JP, Alemzadeh R, Langley G, et al. Beneficial effects of metformin in normoglycemic, morbidly obese adolescents. Metabolism 2001;50:1457–61
   PubMed Web of Science ®Google Scholar
• Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403
   PubMed Web of Science ®Google Scholar
• Robinson TN. Reducing children’s television viewing to prevent obesity: a randomized controlled trial. JAMA 1999;282:1561–7
   PubMed Web of Science ®Google Scholar
• Epstein LH, Valoski AM, Kalarchian MA, et al. Do children lose and maintain weight easier than adults: a comparison of child and parent weight changes from six months to ten years. Obes Res 1995;3:411–7
   PubMedGoogle Scholar
• The Diabetes Control and Complication Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complication in insulin dependent diabetes mellitus. N Engl J Med 1993;329:977–86
   Google Scholar
• Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–53
   PubMed Web of Science ®Google Scholar
• Jones KL, Arslanian S, Peterokova VA, et al. Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 2003;25:89–94
   Web of Science ®Google Scholar
• Daaboul JJ, Siverstein JH. The management of type 2 diabetes in children and adolescents. Minerva Pediatr 2004;56:255–64
   PubMedGoogle Scholar
• Product Information: Glucophage^® (metformin). Bristol-Myers Squibb; Princeton, NJ, 2003
   Google Scholar
• Kaufman FR. Type 2 diabetes in children and youth. Endocrinol Metab Clin N Am 2005;34:659–76
   PubMed Web of Science ®Google Scholar
• Vivian EM, Gutierrez A, Olarte S. Insulin strategies for type 2 diabetes mellitus. Ann Pharmacother 2004;38: 1916–23
   Google Scholar
• Mudaliar S, Edelman SV. Insulin therapy in type 2 diabetes. Endocrinol Metab Clin North Am 2001;30:935–981
   PubMed Web of Science ®Google Scholar
• Riddle MC, Rosenstock J, Gerich J. The treat to target trial. Diabetes Care 2003;26:3080–6
   Google Scholar
• Delea TE, Edelsberg JS, Hagiwara M, et al. Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study. Diabetes Care 2003;26:2983–9
   PubMed Web of Science ®Google Scholar
• Owens Dr, Zinman B, Bolli GB. Insulins today and beyond. Lancet 2001;358:739–46
   PubMed Web of Science ®Google Scholar
• Cook S, Weitzman M, Auinger P, et al. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third national health and nutrition examination survey, 1988–1994. Arch Pediatr Adolesc Med 2003;157:821–7
   PubMed Web of Science ®Google Scholar
• National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III), third report: executive summary. JAMA 2001;285:2486–97
   PubMed Web of Science ®Google Scholar
• Ferranti SD, Gauvreau K, Ludwig DS, et al. Prevalence of the metabolic syndrome in American adolescents. Circulation 2004;110:2494–7
   PubMed Web of Science ®Google Scholar
• Duncan GE, Li SM, Zhou XH. Prevalence and trends of a metabolic syndrome phenotype among U.S. adolescents, 1999–2000. Diabetes Care 2004;27: 2438–43
   Google Scholar
• American Diabetes Association: management of dyslipidemia in children and adolescents with diabetes. Diabetes Care 2003;26:2194–7
   PubMed Web of Science ®Google Scholar
• De Jongh S, Ose L, Szamosi T, et al. Simvastatin in Children Study Group: efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double- blind, placebo-controlled trial with simvastatin. Circulation 2002;106:2231–7
   PubMed Web of Science ®Google Scholar
• Stein EA, Illingworth DR, Kwiterovich Jr PO, et al. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA 1999;281:137–144
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289:2560–72
   PubMed Web of Science ®Google Scholar
• The fourth report on the diagnosis, evaluation,, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:555–76
   Google Scholar
• Rosner B, Prineas RJ, Loggie JM, et al. Blood pressure nomograms for children and adolescents, by height, sex, and age, in the United States. J Pediatr 1993;123:871–86
   PubMed Web of Science ®Google Scholar